Search REXPN

  • PDF File InFocus_Vol3_2025.pdf

    Site: ncsbn.org

    Some of the most impactful leaders I’ve known are those who lead quietly, lifting others without fanfare. There were challenges, of course. We led through a global pandemic, ongoing workforce pressures and rising demands on nursing Adrian’s active involvement with NCSBN throughout his leadership journey. continued on page 26 By Adrian Guerrero, CPM, Director of Operations, Kansas State Board of Nursing Adrian Guerrero served on the NCSBN Board of Directors from 2015 to 2023, including two terms as board treasurer. With more than 28 years of experience in Kansas state government, Guerrero is passionate about regulatory innovation, cybersecurity and public service. https://ksbn.kansas.gov/ 26 | In Focus 2025, Vol. 3 | 27 regulators.

  • PDF File CJIS_Security_Policy_v5-9-4_20231220.pdf

    Site: ncsbn.org

    U. S. Department of Justice Federal Bureau of Investigation Criminal Justice Information Services Division Criminal Justice Information Services (CJIS) Security Policy Version 5.9.4 12/20/2023 Prepared by: FBI CJIS Information Security Officer Approved by: CJIS Advisory Policy Board 12/20/2023 CJISSECPOL v5.9.4 i EXECUTIVE SUMMARY Law enforcement needs timely and secure access to services that provide data wherever and whenever for stopping and reducing crime. In response to these needs, the Advisory Policy Board (APB) recommended to the Federal Bureau of Investigation (FBI) that the Criminal Justice Information Services (CJIS) Division authorize the expansion of the existing security management structure in 1998.

  • Locked PDF File Transcript_2022DCM_avandergaag.pdf

    Site: ncsbn.org

    We ensured that we had data-sharing agreements in place in each of the jurisdictions. As you can imagine, that's very different in Texas from Australia or London. So, we had lawyers involved. We ensured that legal agreements were in place, in terms of data sharing. Everything we received through a secure portal was de-identified before it was transferred. And as I've started to illustrate, we were incredibly keen to get as many regulatory staff, disciplinary staff, involved from the start in the design. So, we were testing all the time with them what we were doing.

  • Locked PDF File KMBT_C654-20131003090749

    Site: ncsbn.org

    KMBT_C654-20131003090749 NATIONAL COUNCIL OF STATE BOARDS OF NURSING, INC. 1 Minutes of the 43rd Annual Delegate Assembly 2 3 Online Business Meeting 4 Meeting I – August 18, 2021 5 6 Call to Order 7 The first business meeting of the 43rd Annual Delegate Assembly of the National Council of State Boards 8 of Nursing was called to order at 2:10 pm Central Time on Wednesday, August 18, 2021, via an 9 online platform. 10 11 Welcome 12 President Douglas welcomed those present. 13 14 Introductions 15 ...

  • ORBS_Nurse_Portal_Training_Manual.docx

    Site: ncsbn.org

    Complete the fields with the certification information given to you by the facilitator 24. Select Save and Continue 25. Skip to Eligibility Questions NCLEX Information In the NCLEX Information section, the Portal User is asked about their NCLEX history. Notice how additional information is required upon selecting Yes . 26. Have you ever taken the NCLEX ? Select, Yes Portal Users must choose the exam type, provide the date of the test and select what state/territory the Portal User registered for the NCLEX . If the Portal User has taken the NCLEX multiple times, they will select +Add another NCLEX exam . 27.

  • Locked PDF File 2025dcm_bush-batchelder3.pdf

    Site: ncsbn.org

    ABC Pharmacy records indicated in part: • On three occasions from 02/22/2022-09/29/2022, the Respondent ordered 1700 lorazepam tabs (page 133). • 1500 tabs of 1 mg lorazepam • 200 tabs of 2 mg lorazepam • In her statement regarding the lorazepam, the Respondent noted in part: • The Respondent confirmed she received 1700 tabs of lorazepam from 03/04/2022-11/17/2022 (page 26). • Respondent noted she dispensed none of the 1700 lorazepam tabs to any patient at either the location.(pages 28-29,31). • The Respondent did not provide any patient medical records. Phentermine: On three occasions from 03/04/2022-11/17/2022, the Respondent ordered 500 tabs of phentermine from ABC Pharmacy.

  • PDF File REx-PN_0122_Bulletin_FR_Final.pdf

    Site: rexpn.com

    J’accepte également les conditions générales de la politique sur les données biométriques du NCSBN présentées aux pages 4 à 8. Je comprends les renseignements fournis et j’accepte de respecter les Règles pour les candidats à l’examen de NCSBN. J’accepte de collaborer à l’enquête de l’administrateur de l’examen sur un comportement non conforme présumé, y compris la remise de tout matériel suspect d’étude ou de préparation à l’examen.

  • PDF File Bulletin des candidates et candidats à l’examen REx-PN

    Site: rexpn.com

    S’inscrire à l’examen REx-PN auprès de Pearson VUE. 4. Recevoir un courriel de Pearson VUE accusant réception de votre inscription à l’examen REx-PN. 5. L’organisme de réglementation des soins infirmiers établira votre admissibilité dans le système de Pearson VUE. 6. Recevoir un courriel d’autorisation pour l’examen (AutE) de la part de Pearson VUE. 7.

  • PDF File Bulletin des candidates et candidats à l’examen REx-PN

    Site: rexpn.com

    S’inscrire à l’examen REx-PN auprès de Pearson VUE. 4. Recevoir un courriel de Pearson VUE accusant réception de votre inscription à l’examen REx-PN. 5. L’organisme de réglementation des soins infirmiers établira votre admissibilité dans le système de Pearson VUE. 6. Recevoir un courriel d’autorisation pour l’examen (AutE) de la part de Pearson VUE. 7.

  • PDF File 2024_REx-PN_Candidate_Bulletin_French_FINAL.pdf

    Site: rexpn.com

    S’inscrire à l’examen REx-PN auprès de Pearson VUE. 4. Recevoir un courriel de Pearson VUE accusant réception de votre inscription à l’examen REx-PN. 5. L’organisme de réglementation des soins infirmiers établira votre admissibilité dans le système de Pearson VUE. 6. Recevoir un courriel d’autorisation pour l’examen (AutE) de la part de Pearson VUE. 7.